|
AREDS2 DNA
|
|
|
The table below features independently searchable categories based on different clinical variables collected in the AREDS2 study to aid in sample selection.
|
Click here to view the Local ID/Tube ID, Coriell Sample ID, and dbGaP Submitter Subject ID (ID2) of all DNA samples in the NEI-AREDS2 Repository.
|
| AMD or Control (Count) | Sex (Count) | Race (Count) | Age (Count) | Max Baseline AMD Severity (Count) | Max Final AMD Severity (Count) |
| AMD (1931) | Female (1156) | Asian (16) | 50-54 Yrs (40) | 1 - AREDS AMD Severity Scale Step 1 (1) | 1 - AREDS AMD Severity Scale Step 1 (0) |
| Control (48) | Male (823) | Black or African American (20) | 55-59 Yrs (114) | 2 - AREDS AMD Severity Scale Step 2 (12) | 2 - AREDS AMD Severity Scale Step 2 (2) |
| | Native Hawaiian or other Pacific (2) | 60-64 Yrs (217) | 3 - AREDS AMD Severity Scale Step 3 (13) | 3 - AREDS AMD Severity Scale Step 3 (10) |
| | Other (15) | 65-69 Yrs (342) | 4 - AREDS AMD Severity Scale Step 4 (59) | 4 - AREDS AMD Severity Scale Step 4 (18) |
| | White (1926) | 70-74 Yrs (440) | 5 - AREDS AMD Severity Scale Step 5 (97) | 5 - AREDS AMD Severity Scale Step 5 (42) |
| | | 75-79 Yrs (503) | 6 - AREDS AMD Severity Scale Step 6 (287) | 6 - AREDS AMD Severity Scale Step 6 (91) |
| | | 80-84 Yrs (295) | 7 - AREDS AMD Severity Scale Step 7 (573) | 7 - AREDS AMD Severity Scale Step 7 (438) |
| | | 85-89 Yrs (28) | 8 - AREDS AMD Severity Scale Step 8 (181) | 8 - AREDS AMD Severity Scale Step 8 (158) |
| | | | 9 - AREDS AMD Severity Scale Step 9 (73) | 9 - AREDS AMD Severity Scale Step 9 (93) |
| | | | 10 - Central GA (53) | 10 - Central GA (208) |
| | | | 11a - Neovascular AMD with definite presence of one of the following five characteristics of neovascular AMD: SSR detachment, PED, subretinal/sub-RPE hemorrhage, hard exudate, or fibrous tissue (21) | 11a - Neovascular AMD with definite presence of one of the following five characteristics of neovascular AMD: SSR detachment, PED, subretinal/sub-RPE hemorrhage, hard exudate, or fibrous tissue (8) |
| | | | 11b - Neovascular AMD with end-stage disease (e.g., definite disciform scar, or photocoagulation scar), or two or more of the following five characteristics of neovascular AMD: SSR detachment, PED, subretinal/sub-RPE hemorrhage, hard exudate, or fibrous tissue (561) | 11b - Neovascular AMD with end-stage disease (e.g., definite disciform scar, or photocoagulation scar), or two or more of the following five characteristics of neovascular AMD: SSR detachment, PED, subretinal/sub-RPE hemorrhage, hard exudate, or fibrous tissue (863) |
|
|
|
|